Peripheral biomarkers of stroke: Focus on circulatory microRNAs
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1862 (10) , 1984-1993
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG042178, AG47812)
- Garrison Family Foundation
This publication has 87 references indexed in Scilit:
- MicroRNA-103-1 Selectively Downregulates Brain NCX1 and Its Inhibition by Anti-miRNA Ameliorates Stroke Damage and Neurological DeficitsMolecular Therapy, 2014
- Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humansBMC Neurology, 2013
- MicroRNA-210 as a novel blood biomarker in acute cerebral ischemiaFrontiers in Bioscience-Elite, 2011
- Using microRNAs to understand cancer biologyThe Lancet Oncology, 2010
- Elevated Serum S100B Levels Indicate a Higher Risk of Hemorrhagic Transformation After Thrombolytic Therapy in Acute StrokeStroke, 2007
- Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery InfarctionArchives of Neurology, 2005
- Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic StrokeStroke, 2004
- Genetics and ischaemic strokeBrain, 2000
- Preexisting Dementia in Stroke PatientsStroke, 1997
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993